HIGHLIGHTS
- Who: Thomas Gabriel Schreiner and collaborators from the Department of Medical Specialties III, Faculty of Medicine, "Grigore TPopa" University of Medicine and have published the article: Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact, in the Journal: Biomedicines 2024, 1096 of /2024/
- Future: This debatable aspect must be investigated in future studies including research focused on a better understanding of the crosstalk between Aβ pathology and other relevant aspects of AD such as Tau protein accumulation neuroinflammation and oxidative stress as has already been pointed out in several works . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.